Corvus Pharmaceuticals, Inc. (CRVS)
13.93
-0.46
(-3.20%)
USD |
NASDAQ |
Sep 08, 16:00
13.93
0.00 (0.00%)
Pre-Market: 08:06
Corvus Pharmaceuticals Price to Book Value : 5.200 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 5.200 |
| September 04, 2026 | 5.372 |
| September 03, 2026 | 5.469 |
| September 02, 2026 | 5.301 |
| September 01, 2026 | 5.327 |
| August 31, 2026 | 5.242 |
| August 28, 2026 | 5.286 |
| August 27, 2026 | 5.495 |
| August 26, 2026 | 5.499 |
| August 25, 2026 | 5.436 |
| August 24, 2026 | 5.260 |
| August 21, 2026 | 5.398 |
| August 20, 2026 | 5.350 |
| August 19, 2026 | 5.749 |
| August 18, 2026 | 5.536 |
| August 17, 2026 | 5.566 |
| August 14, 2026 | 5.559 |
| August 13, 2026 | 5.652 |
| August 12, 2026 | 5.619 |
| August 11, 2026 | 5.499 |
| August 10, 2026 | 5.130 |
| August 07, 2026 | 5.197 |
| August 06, 2026 | 5.174 |
| August 05, 2026 | 5.200 |
| August 04, 2026 | 5.197 |
| Date | Value |
|---|---|
| August 03, 2026 | 4.991 |
| July 31, 2026 | 4.950 |
| July 30, 2026 | 4.924 |
| July 29, 2026 | 4.868 |
| July 28, 2026 | 4.969 |
| July 27, 2026 | 4.823 |
| July 24, 2026 | 4.879 |
| July 23, 2026 | 5.107 |
| July 22, 2026 | 5.223 |
| July 21, 2026 | 5.402 |
| July 20, 2026 | 5.264 |
| July 17, 2026 | 5.563 |
| July 16, 2026 | 5.327 |
| July 15, 2026 | 5.57 |
| July 14, 2026 | 5.589 |
| July 13, 2026 | 5.492 |
| July 10, 2026 | 5.85 |
| July 09, 2026 | 6.048 |
| July 08, 2026 | 6.003 |
| July 07, 2026 | 5.835 |
| July 06, 2026 | 5.663 |
| July 02, 2026 | 5.686 |
| July 01, 2026 | 5.510 |
| June 30, 2026 | 5.578 |
| June 29, 2026 | 5.059 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.633 |
| Alnylam Pharmaceuticals, Inc. | 25.69 |
| Anika Therapeutics, Inc. | 2.051 |
| Savara, Inc. | 7.907 |
| Vericel Corp. | 5.404 |
Price to Book Value Related Metrics
| Price | 13.93 |
| Earnings Yield | -4.43% |
| Market Cap | 1.172B |